← All organizations

The Neurological Institute, PA

Academic/Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 1, 2012

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

dalfampridine

Phase 1 (1 own, 0 via acquisition)

vx15/2503

Indications

Studied for

Recent trials (2)

NCT01764737Overall official - principal investigatorPhase 1Dec 1, 2012
NCT01328379Overall official - principal investigatorPhase 3Mar 1, 2011

Details

Last known activity: Dec 1, 2012